SEC Form 4 · accession 0001250853-15-000043
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 4, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common STock | Jun 2, 2015 | M | 8,333 | $0.32 | A | 60,833 | D | |
| Common Stock | Jun 2, 2015 | M | 8,750 | $1.37 | A | 69,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.32 | Jun 2, 2015 | M | 8,333 | A | — | Feb 4, 2023 | Common Stock | 8,333 | 14,167 | D |
| Stock Option (right to buy)F2 | $1.37 | Jun 2, 2015 | M | 8,750 | A | — | Aug 29, 2023 | Common Stock | 8,750 | 11,250 | D |
Explanation of responses
- F1The option vested as to 10,000 shares on November 1, 2013 and the remaining shares vest in equal monthly installments over the following 36 months.
- F2The option vested as to 5,000 shares on August 29, 2014 and the remaining shares vest in equal monthly installments over the following 36 months.